Affordable Access

[Behavioral, cellular and molecular consequences of the dopamine transporter gene inactivation].

Authors
  • Jaber, M
  • Bloch, B
  • Caron, M G
  • Giros, B
Type
Published Article
Journal
Comptes rendus des séances de la Société de biologie et de ses filiales
Publication Date
Jan 01, 1998
Volume
192
Issue
6
Pages
1127–1137
Identifiers
PMID: 10101608
Source
Medline
License
Unknown

Abstract

Mice lacking the the plasma membrane dopamine transporter (DAT), following gene inactivation or knock out, show an increase in their spontaneous locomotor activity that is of the same magnitude than in normal mice treated with amphetamine or cocaine, known to increase levels of dopamine in the basal ganglia. Many adaptive responses have occurred in these animals than could not compensate for the hyper activity of the dopamine system. Surprisingly, while intracellular dopamine levels were of only 5%, extracellular dopamine levels were increased by 300%. We investigated the regulation of tyrosine hydroxylase (TH), the rate limiting enzyme of dopamine synthesis, and found that this enzyme is regulated at the levels of mRNA, protein, trafficking as well as in its regional, cellular and subcellular organization. Our results establish not only the central importance of the transporter as the key element controlling dopamine levels in the brain, but also its role in the behavioral and biochemical action of amphetamine, cocaine and morphine. In addition, these mice have provided key elements leading to possible clinical and social implications for illnesses such as Parkinson disease, attention deficit disorder and drug addiction.

Report this publication

Statistics

Seen <100 times